Back
Cytokinetics Stock Predictions
Sponsored
CYTK
Sponsored
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
42
CYTK
Cytokinetics
Last Price:
$48.93
Seasonality Move:
7.19%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.Cytokinetics Stock Forecast
-
Over the next 52 weeks, Cytokinetics has on average historically risen by 10.3% based on the past 20 years of stock performance.
-
Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
-
Is Cytokinetics Stock Undervalued?The current Cytokinetics [CYTK] share price is $48.96. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cytokinetics Stock Go Up Next Year?
-
Over the next 52 weeks, Cytokinetics has on average historically risen by 10.3% based on the past 20 years of stock performance.
Cytokinetics Stock Rating
Sell
42
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics overpriced?
-
Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
Cytokinetics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com
52-Week Data
52-Week High:
110.25
52-Week Low:
43.21
Prediction Charts
Market Cap:
5.8B
Price in USD:
48.96
Volume:
3.5M
Beta:
1.44
Technical Analysis
SMA50:
52.00
SMA100:
53.59
SMA200:
57.10
52-Wk Change:
37.07%
Stock Predictions
-
Is Cytokinetics stock public?Yes, Cytokinetics is a publicly traded company.
-
What is the Cytokinetics stock quote today?The Cytokinetics stock price is 48.96 USD today.
-
How to buy Cytokinetics stock online?You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-3 | 50.52 | 51.51 | 51.80 | 49.95 |
Dec-4 | 51.21 | 50.44 | 51.53 | 50.38 |
Dec-5 | 49.78 | 50.40 | 50.65 | 49.73 |
Dec-6 | 50.57 | 50.96 | 51.98 | 50.15 |
Dec-9 | 51.18 | 50.50 | 51.71 | 50.21 |
Dec-10 | 50.38 | 50.55 | 51.26 | 50.12 |
Dec-11 | 50.42 | 50.70 | 50.90 | 49.84 |
Dec-12 | 50.29 | 50.24 | 50.68 | 49.52 |
Dec-13 | 50.10 | 48.65 | 50.24 | 48.14 |
Dec-16 | 48.61 | 49.02 | 49.58 | 48.54 |
Dec-17 | 48.50 | 47.78 | 49.04 | 47.38 |
Dec-18 | 48.00 | 46.36 | 49.40 | 46.00 |
Dec-19 | 46.45 | 46.74 | 47.30 | 45.66 |
Dec-20 | 46.85 | 48.96 | 50.32 | 46.85 |
Cytokinetics Earnings
Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cytokinetics Forecast Revenue Growth
Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.02 per share.
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.